Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES TrialsAshutosh D Wechalekar, Angela Dispenzieri, Vaishali Sanchorawala, et al.Ejhaem|June 9, 2025
Final Results of a Phase 2 Multi-Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple MyelomaBarry Paul, Jiri Minarik, Francesca Cottini, et al.Bone Marrow Transplantation|August 13, 2020
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myelomaChristopher Lemieux, Lori S Muffly, Andrew Rezvani, et al.Nature Communications|February 20, 2025
Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myelomaHitomi Hosoya, Mia Carleton, Kailee Tanaka, et al.Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretinSravan C Penchala, Stephen Connelly, Yu Wang, et al.Blood Advances|October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 studyIbrahim Aldoss, Jun Yin, Anna Wall, et al.Blood Advances|September 7, 2021
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALLMatthew J Wieduwilt, Jun Yin, Meir Wetzler, et al.British Journal of Haematology|June 26, 2018
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myelomaPaul G Richardson, Craig C Hofmeister, Cara A Rosenbaum, et al.The Journal of Experimental Medicine|July 26, 2022
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphomaYu Rebecca Miao, Kaushik Thakkar, Can Cenik, et al.Blood Neoplasia|August 12, 2025
Real-world performance of the CALGB 10403 regimen in young adults in the United StatesBrandon DaSilva, Alicia Darwin, Amy Zhang, et al.Pageof 11